Divergent effects of ischemia/reperfusion and nitric oxide donor on TNFα mRNA accumulation in rat organs

Shock

Volumn 15, Issue 4, 2001, Pages 312-317

  Rahat, Michal A ^a   Lahat, Nitza ^a,b   Smollar, Julia ^a   Brod, Vera ^a   Kinarty, Amalia ^a   Bitterman, Haim ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

Autocrine paracrine action; RT PCR; Semiquantitative; Shock; SNAP; Splanchnic ischemia; Superior mesenteric artery

Indexed keywords

DRUG DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LACTIC ACID DERIVATIVE; MESSENGER RNA; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, RAT; PENICILLAMINE; S NITRO N ACETYLPENICILLAMINE; S-NITRO-N-ACETYLPENICILLAMINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL TRANSLOCATION; BIOSYNTHESIS; BLOOD; BLOOD PRESSURE; BRAIN; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENERAL ANESTHESIA; GENETICS; HEART MUSCLE; HEMATOCRIT; INTESTINE; ISCHEMIA; LAPAROTOMY; LIGATION; LIVER; LUNG; LYMPH NODE; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PH; POLYMERASE CHAIN REACTION; RANDOMIZATION; RAT; REPERFUSION INJURY; SPLANCHNIC BLOOD FLOW; SPLEEN; SPRAGUE DAWLEY RAT; SUPERIOR MESENTERIC ARTERY; VASCULARIZATION;

ANESTHESIA, GENERAL; ANIMALS; BACTERIAL TRANSLOCATION; BLOOD PRESSURE; BRAIN; CONSTRICTION; GENE EXPRESSION REGULATION; HEMATOCRIT; HYDROGEN-ION CONCENTRATION; INTESTINES; ISCHEMIA; LACTATES; LAPAROTOMY; LIVER; LUNG; LYMPH NODES; MALE; MESENTERIC ARTERY, SUPERIOR; MYOCARDIUM; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SPECIFICITY; OXIDATIVE STRESS; PENICILLAMINE; POLYMERASE CHAIN REACTION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RNA, MESSENGER; SPLANCHNIC CIRCULATION; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035315949     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200115040-00011     Document Type: Article

References (49)

1. Bynum TE, Gallavan RH, Jacobson ED: The pathophysiology of nonocclusive intestinal ischemia. In Shepherd AP, Granger DN (eds): Physiology of the Intestinal Circulation. New York: Raven Press, 1984, pp 369-377.
2. Patel A, Kaleya RN, Sammartano RJ: Pathophysiology of mesenteric ischemia. Surg Clin North Am 72:31-41, 1992.
3. Mitsudo S, Brandt LJ: Pathology of intestinal ischemia. Surg Clin North Am 72:41-63, 1992.
4. Menge H, Robinson JWL: Early phase of jejunal regeneration after short term ischemia in the rat. Lab Invest 40:25-30, 1979.
5. Brown BA, Chiu CJ, Scott HJ, Gurd FN: Ultrastructural changes in the canine ileal mucosal cell after mesenteric arterial occlusion. Arch Surg 101:290-299, 1970.
6. Bitterman H, Aoki N, Lefer AM: Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion shock. Proc Soc Exp Biol Med 188: 265-271, 1988.
7. Zimmerman BJ, Granger DN: Reperfusion injury. Surg Clin North Am 72:65-83, 1992.
8. Lefer AM, Lefer DJ: Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol 33:71-90, 1993.
9. Bitterman H, Kinarty A, Lazarovich H, Lahat N: Acute release of cytokines is proportional to tissue injury induced by surgical trauma and shock in rats. J Clin Immunol 11:184-192, 1991.
10. Panes J, Granger DN: Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 114: 1066-1090, 1998.
11. Hadjiminas DJ, McMasters KM, Peyton JC, Cheadle WG. Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture of intraperitoneal injection of endotoxin. J Surg Res 56:549-555, 1994.
12. Beutler B, Cerami A: Tumor necrosis, cachexia, shock and inflammation: a common mediator. Annu Rev Biochem 57:505-518, 1988.
13. Tracey KJ, Cerami A: Tumor necrosis factor: a pleoitropic cytokine and therapeutic target. Annu Rev Med 45:491-503, 1994.
14. Frangogiannis NG, Lindsey ML, Michael LH, Youker KA, Bressler RB, Mendoza LH, Spengler RN, Smith CW, Entman ML: Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98:699-710, 1998.
15. Suzuki S, Nakamura S, Sakaguchi T, Ochiai H, Konno H, Baba S, Baba S. Alternation of reticuloendothelial phagocytic function and tumor necrosis factor-alpha production after total hepatic ischemia. Transplantation 64:821-827, 1997.
16. 2 by macrophages isolated after thermal injury and bacterial translocation. Circ Shock 42:154-162, 1994.
17. Cohen S, Lahat N, Kinarty A, Bitterman H: Ex Vivo secretion of tumor necrosis factor and interleukin-2 by rat splenocytes after intestinal ischemia and shock. Lymphokine Cytokine Res 11:215-220, 1992.
18. Shito M, Wakabayashi G, Ueda M, Shimazu M, Shirasugi N, Endo M, Mukai M, Kitajima M: Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 63:143-148, 1997.
19. Botchkina GI, Meistrell ME III, Botchkina IL, Tracey KJ: Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med 3:765-781, 1997.
20. Meldrum DR, Shames BD, Meng X, Fullerton DA, McIntyre RC Jr, Grover FL, Harken AH: Nitric oxide downregulates lung macrophage inflammatory cytokine production. Ann Thorac Surg 66:313-317, 1998.
21. Gauthier TW, Davenpeck KL, Lefer AM: Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol 267:G562-G568, 1994.
22. Davenpeck KL, Gauthier TW, Lefer AM: Inhibition of endothelium-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 107:1050-1058, 1994.
23. Arndt H, Russell JB, Kurose I, Kubes P, Granger DN: Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology 105:675-680, 1993.
24. Kurose I, Wolf R., Grisham MB, Granger DN: Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 74: 376-382, 1994.
25. Busse R, Fleming I: Regulation and functional consequences of endothelial nitric oxide formation. Ann Med 27:331-340, 1995.
26. Xie QW, Nathan C: The high output nitric oxide pathway: role and regulation. J Leukoc Biol 56:576-582, 1994.
27. Yoshizumi M, Perrela M, Burnett JC Jr, Lee ME: TNF down regulates the endothelial nitric oxide synthase mRNA by shortening its half life. Circ Res 73:205-209, 1993.
28. Hickey MJ, Sharkey KA, Sinhota EG, Reinhardt PH, MacMicking JD, Nathan C, Kubes P: Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 11:955-964, 1997.
29. MacMicking J, Xie QW, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350, 1997.
30. Peng HB, Spiecker M, Liao JK: Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol 161:1970-1976, 1998.
31. Kolb H, Kolb-Bachofen V: Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunology Today 19:556-561, 1998.
32. Mohamed F, Monge JC, Gordon A, Cernacek P, Blais D, Stewart DJ: Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arteriorscler Thromb Vasc Biol 15:52-57, 1995.
33. Oswald IP, Wynn TA, Sher A, James SL: NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines. Comp Biochem Physiol Pharmacol Tooxicol Endocrinol 108:11-18, 1994.
34. Christopher TA, Ma XL, Lefer AM: Beneficial actions of S-nitroso-N-ascetylpenicillamine, a nitric oxide donor, in murine traumatic shock. Shock 1:19-24, 1994.
35. Sun D, Coleclough C, Cao L, Hu X, Sun S, Whitaker JN: Reciprocal stimulation between TNFα and NO may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis. J Neuroimmunol 89:122-130, 1998.
36. Zinetti M, Fantuzzi G, Delgado R, Di Santo E, Ghezzi P, Fratelli M: Endogenous nitric oxide production by human monocytic cells regulates LPS-induced TNF production. Eur Cytokine Netw 6:45-48, 1995.
37. Eigler A, Sinha B, Endres S: Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem Biophys Res Commun 196:494-501, 1993.
38. Van DerVort AL, Yan L, Madara PJ, Cobb JP, Wesley RA, Corriveau CC, Tropea MM, Danner RL: Nitric oxide regulates endoxin-induced TNFα production by human neutrophils. J Immunol 152:4102-4108, 1994.
39. Sinha B, Eigler A, Baumann KH, Greten TF, Moeller J, Endres S. NO down regulates TNFα mRNA in RAW 264.7 cells. Res Immunol 149:139-150, 1998.
40. Eigler A, Moeller J, Endres S: Exogenous and endogenous nitric oxide attenuates umor necrosis factor synthesis in the murine macrophage cell line RAW 264.1. J Immunol 154:4048-4054, 1995.
41. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15:532-537, 1993.
42. Horikoshi, T, Danenberg KD, Stadlbauer THW, Volkenandt M, Shea LCC, Aigner K, Gustavsson B, Leichman L, Frosing R, Ray M, Gibson NW, Spears CP, Danenberg PV: Quantitation of thymidylate synthase, dihydrofolate reductase and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res 52:108-116, 1992.
43. Nathens AB, Rotstein OD, Dackiw PB, Marshall JC: Intestinal epithelial cells down-regulate macrophage tumor necrosis factor-alpha secretion: a mechanism for immune homeostasis in the gut-associated lymphoid tissue. Surgery 118: 343-351, 1995.
44. Grotz MRW, Ding J, Guo W, Huang Q, Deitch EA: Comparison of plasma cytokine levels in rats subjected to superior mesenteric artery occlusion or hemorrhagic shock. Shock 3:362-368, 1995.
45. Lahat N, Rahat MA, Brod V, Cohen S, Weber G, Kinarty A, Bitterman H: Abdominal surgery reduces the ability of rat spleen cells to synthesize and secrete active TNF-α by a multilevel regulation. Clin Exp Immunol 115:19-25, 1999.
46. Beutler B, Han J, Kruys V, Giroir P: Coordinate regulation of TNF biosynthesis at the level of transcription and translation. In Beutler B (ed.): Tumor Necrosis Factors: the Molecules and Their Emerging Role in Medicine. New York: Raven Press, 1992, pp 561-573.
47. Han J, Brown T, Beutler B: Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the transcriptional level. J Exp Med 171: 465-475, 1990.
48. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immuno-logically inducible TNFα/cachetin. Nature 346:274-276, 1990.
49. Hacham M, Cristal N, White RM, Segal S, Apte RN: Complementary organ expression of IL-1 vs. IL-6 and CSF-1 activites in normal and LPS-injected mice. Cytokine 8:21-31, 1996.